Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Rising Prevalence of Skin and Food Allergies to Steer Allergy Care Market Past US$ 40 Billion by 2032

FactMR Logo

News provided by

Fact.MR

Sep 19, 2022, 08:30 ET

Share this article

Share toX

Share this article

Share toX

North America to Remain at the Top of the Ladder, Contributing Nearly 1/5th of Overall Allergy Care Sales

In its latest study, Fact.MR offers a detailed analysis of the global allergy care market from 2022 to 2032. The report analyzes key factors such as drivers, trends, and challenges that are influencing allergy care product sales. Beside this, it highlights opportunities across various segments, including allergy type, product type, form, sales channel, and region.

NEW YORK, Sept. 19, 2022 /PRNewswire/ -- The global allergy care market size is projected to grow from US$ 22 Billion in 2022 to US$ 40 Billion in 2032, with overall sales accelerating at a healthy CAGR of 6.1% over the forecast period (2022-2032).

Increasing incidence of various types of allergies caused by Asthma, dust, etc., growing popularity of OTC drugs, and introduction of novel, and effective allergy care products are some of the key factors driving the global allergy care market.

The healthcare industry has been alarmed by the rising number of fatalities related to different allergies. Consequently, the need for efficient allergy therapies has increased over time. As a result, this element has the potential to greatly expand the allergy treatment industry.

Similarly, increasing investments in research and development (R&D) along with rise in the number of product launches will bode well for the allergy care market during the next ten years. Leading manufacturers are continuously focusing towards developing more effective allergy care products to help patients to relieve their symptoms.

Get A Sample Copy of this Report!

https://www.factmr.com/connectus/sample?flag=S&rep_id=2382

In addition to this, increasing government efforts to tackle the global burden of allergies is expected to generate lucrative growth opportunities for allergy care product manufacturers during the forecast period.

Regionally, North America will continue to dominate the global allergy care market during the forecast period, owing to the rapid surge in allergy cases, high levels of healthcare awareness among people, and strong presence of leading pharmaceutical giants in countries like the U.S. Fact.MR predicts the North American allergy care market to increase by 1.5X through 2032.

Key Takeaways:

  • By product type, revenue from antihistamine medication segment is expected to grow by 1.4X as compared to nasal spray segment.
  • By sales channel, drug & pharmacies stores segment accounts for around 52.4% share of the global allergy care market and is likely to retain its dominance during the forecast period.
  • North America will continue to dominate the global allergy care market, accounting for the largest share of around 23.8% in 2022.
  • With rising spending on allergy care products, the U.S. holds around 19.2% to the overall market share.
  • Demand for allergy care products in Europe is expected to grow by 1.3X during the forecast period.

Growth Drivers:

  • Rising prevalence of allergies along with increasing need for effective allergy therapies will continue to bolster market growth during the forecast period.
  • Growing trend of telehealth and telemedicine in allergy care is expected to foster sales of allergy care products during the next ten years.
  • Increasing awareness about various types of allergies and their treatments due to various government initiatives and campaigns is acting as a catalyst triggering market growth.

Restraints:

  • Underdiagnosis of allergies is a key factor restraining the growth in the market.
  • High cost of some allergy care products might also limit their adoption across lower economies.

Get A Customize Report as per Your Requirements!

https://www.factmr.com/connectus/sample?flag=RC&rep_id=2382

Competitive Landscape:

The allergy care market is expected to witness steady growth as a result of increased financing in research and development (R&D) among key companies. For the purpose of consolidating their positions in the market, key players are emphasizing on mergers, acquisitions, joint ventures, collaborations, and partnerships.

They are also focusing on fast-tracking the approval for their product by regulatory authorities such as the U.S. Food and Drugs Administration (FDA) and others to gain competitive edge.

For instance,

  • In July 2020, Alcon announced that it has received the FDA approval for the OTC switch of Pataday once daily relief additional strength, the first and only eye allergy itch drop offering a full 24 hours of relief without a prescription in the U.S.
  • In 2022, Glenmark Pharma launched Ryaltris nasal spray, the only-approved fixed-dose combination therapy for seasonal allergic rhinitis in the U.S market.

Key Companies Profiled by Fact.MR

  • Johnson & Johnson Services, Inc.
  • Sanofi Aventis U.S. LLC
  • Bayer AG
  • Spirit Pharmaceuticals LLC
  • Abbott
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • LETIPharma
  • Genentech USA, Inc.
  • ALK-Abelló A/S

More Valuable Insights on Allergy Care Market

In the latest study, Fact.MR offers a detailed study on global allergy care market for the forecast period of 2022 to 2032. This study also highlights key drivers promoting the sales of allergy care through detailed segmentation as follows:

By Allergy Type:

  • Eye Allergy
  • Skin Allergy
  • Food Allergy
  • Other Allergies (Rhinitis)

By Product Type:

  • Nasal Spray
  • Antihistamine Medication
  • Eye Drops

By Form:

  • Tablet/Gels/Pills
  • Sprays
  • Liquids

By Sales Channel:

  • Drug & Pharmacies Stores
  • Modern Trade
  • Departmental Stores
  • Institutional Sales
  • Monobrand Stores
  • Online Retailers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Interested to Procure The Data? Inquire here

https://www.factmr.com/connectus/sample?flag=EB&rep_id=2382

Key Questions Covered in the Allergy Care Market Report

  • What is the projected value of the allergy care market in 2022?
  • At what rate will the global allergy care market grow until 2032?
  • Which are the factors hampering the growth in the allergy care market?
  • Which region is expected to lead in the global allergy care market during 2022-2032?
  • Which are the factors driving the allergy care market during the forecast period?
  • What is the expected market value of the allergy care market during the forecast period?

Explore Fact.MR's Coverage on the Consumer Goods Domain

After Sun Care Products Market: As per Fact.MR, the global after sun care product market is anticipated to grow at a CAGR of 3.4% during the forecast period of 2021 and 2031. Increasing women workforce across emerging economies and growing consumer awareness about the importance of skin care products are some of the key factors driving demand for after sun care products in the market.

Mass Beauty & Personal Care Products Market: The global mass beauty & personal care products market is projected to grow at a robust CAGR of 6% between 2021 and 2032, reaching around US$ 800 billion by 2031. Growth in the market is driven by increased acceptance rate and growing popularity of beauty & personal care products. Besides this, growing consumer awareness about their health and safety is also positively impacting market growth.

Premium Beauty and Personal Care Products Market: The global demand for premium beauty & personal care products market is anticipated to grow at a CAGR of 6% between 2021 and 2031, totaling a valuation of US$ 100 billion by 2031. It is anticipated that the market for high-end cosmetic and personal care products would benefit from consumer awareness of premium ingredients and their demonstrated efficacy on the skin.

OTC Cough, Cold, and Allergy Medicine Market: Fact.MR expects the OTC Cough, Cold, and Allergy Medicine industry to be valued at US$ 38.96 Billion by 2022. Bronchodilators Segment is expected to grow the fastest, at a CAGR of 5.4%.

Check it Out More Reports by Fact.MR on Retail Industry

https://www.factmr.com/industry/consumer-goods

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.

Contact: 

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
E: [email protected]

Follow Us: LinkedIn | Twitter | Blog

Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg

SOURCE Fact.MR

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.